UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 9, 2024
Accession Number:
0001437749-24-036590
Submission Type:
POS AM
CIK:
0001659617
Company Name:
Moleculin Biotech, Inc.
File Number:
333-276851